Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 2, 2013, Pages 444-450

  Palma, David A ^a   Senan, Suresh ^b   Tsujino, Kayoko ^c   Barriger, Robert B ^d   Rengan, Ramesh ^e   Moreno, Marta ^f   Bradley, Jeffrey D ^g   Kim, Tae Hyun ^h   Ramella, Sara ⁱ   Marks, Lawrence B ^j   De Petris, Luigi ^k   Stitt, Larry ^l   Rodrigues, George ^a,l  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c HYOGO CANCER CENTER   (Japan)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY CLINIC OF NAVARRA   (Spain)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h National Cancer Center   (South Korea)

ⁱ UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITY OF WESTERN ONTARIO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CHEMORADIATION; CONCURRENT CHEMORADIATION; CONCURRENT CISPLATIN; DATA SETS; DOSE LIMITING TOXICITY; INDIVIDUAL PATIENT DATA; LOGISTIC REGRESSIONS; LUNG CANCER; LUNG VOLUME; META-ANALYSIS; NON SMALL CELL LUNG CANCER; ODDS RATIOS; OVERALL RATE; RADIATION PNEUMONITIS; RECURSIVE PARTITIONING ANALYSIS; RISK FACTORS; SCORING SYSTEMS; SYSTEMATIC REVIEW; TRAINING SETS; TUMOR LOCATION; VALIDATION SETS;

BIOLOGICAL ORGANS; CHEMORADIOTHERAPY; CHEMOTHERAPY; DISEASES; HOSPITAL DATA PROCESSING; LOGISTICS; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

FACTOR ANALYSIS;

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PACLITAXEL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMORADIOTHERAPY; CONCURRENT CHEMORADIATION THERAPY; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG VOLUME; MEDLINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; SYSTEMATIC REVIEW;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIA; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CISPLATIN; DECISION TREES; ETOPOSIDE; EUROPE; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORTH AMERICA; PACLITAXEL; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE;

EID: 84872191887     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.04.043     Document Type: Article

References (20)

1. NCCN clinical practice guideline: non-small cell lung cancer. Available at www.nccn.org. Accessed Oct 1, 2011.
2. G. Rodrigues, M. Lock, and D. D'Souza Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer: a systematic review Radiother Oncol 71 2004 127 138
3. J.D. Bradley, A. Hope, and I. El Naqa A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data Int J Radiat Oncol Biol Phys 69 2007 985 992
4. L.B. Marks, S.M. Bentzen, and J.O. Deasy Radiation dose-volume effects in the lung Int J Radiat Oncol Biol Phys 76 2010 S70 S76
5. R.B. Barriger, A.J. Fakiris, and N. Hanna Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel Int J Radiat Oncol Biol Phys 78 2010 1381 1386
6. L. De Petris, I. Lax, and F. Sirzen Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer Med Oncol 22 2005 375 381
7. T.H. Kim, K.H. Cho, and H.R. Pyo Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer Radiology 235 2005 208 215
8. J. Mao, Z. Kocak, and S. Zhou The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response Int J Radiat Oncol Biol Phys 67 2007 1360 1369
9. M. Moreno, J. Aristu, and L.I. Ramos Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer Clin Transl Oncol 9 2007 596 602
10. E.C. Phernambucq, F.O. Spoelstra, and W.F. Verbakel Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity Ann Oncol 22 2011 132 138
11. S. Ramella, L. Trodella, and T.C. Mineo Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy Int J Radiat Oncol Biol Phys 76 2010 110 115
12. S. Senan, F. Cardenal, and J. Vansteenkiste A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer Ann Oncol 22 2011 553 558
13. K. Tsujino, S. Hirota, and M. Endo Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer Int J Radiat Oncol Biol Phys 55 2003 110 115
14. A.V. Louie, G. Rodrigues, and P. Lee Clinical and technical assessment of respiratory gated intensity modulated radiotherapy for locally advanced lung cancer Int J Radiat Oncol Biol Phys 81 2011 S824
15. A. Orisamolu, E. Xanthopoulos, and A. Fernandes Predictive factors for symptomatic radiation pneumonitis in 293 consecutively treated non-small cell lung cancer (NSCLC) patients receiving definitive radiation therapy J Clin Oncol 29 2011 (suppl; abstr 7041)
16. B. Parashar, A. Edwards, and R. Mehta Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer Am J Clin Oncol 34 2011 160 164
17. H. Onishi, K. Kuriyama, and M. Yamaguchi Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis Lung Cancer 40 2003 79 84
18. A. Ardizzoni, L. Boni, and M. Tiseo Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis J Natl Cancer Inst 99 2007 847 857
19. N. Yamamoto, K. Nakagawa, and Y. Nishimura Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105 J Clin Oncol 28 2010 3739 3745
20. J.D. Bradley, J. Moughan, and M.V. Graham A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117 Int J Radiat Oncol Biol Phys 77 2010 367 372